FDA: Opioid Use Disorder: Endpoints for Demonstrating Effectiveness of Drugs for Medication-Assisted Treatment; Draft Guidance for Industry; Availability

Notice from the Food and Drug Administration seeking comment on a draft guidance entitled "Opioid Use Disorder: Endpoints for Demonstrating Effectiveness of Drugs for Medication-Assisted Treatment," as well as comments on when the use of placebo or active controls is most appropriate in clinical trials for such drugs. Comments are due by October 9, 2018.
Source: Federal Register updates via the Rural Assistance Center - Category: Rural Health Source Type: news